COLON-MD: Colon Cancer Longitudinal Study

Study acronym: COLON-MD
StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Primary and study completion dates changed from estimate of Jun 1, 2026 to May 15, 2026
    • Eligibility criteria expanded, about 11 words
    • Site details revised
  2. Trial status: Active, Not Recruiting to Recruiting
    • Primary and study completion dates: Feb 1, 2025 to Jun 1, 2026
    • Site details revised
    v5
  3. Enrollment target: estimated 112 to confirmed 11
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v4
  4. Primary completion date: Feb 1, 2023 to Feb 1, 2025
    • Eligibility criteria shortened, about 9 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site contact updated
    v3
  5. Primary endpoint revised
    • Secondary endpoint revised
    v2
  6. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this proposal is to identify how the composition of the gut microbiome and diet interact to impact chemotherapy-induced diarrhea incidence and severity.
Trial Details
NCT Number NCT04751448
Lead Sponsor Baylor Research Institute
Collaborators: Baylor University
Conditions
(from sponsor)		 Colon Cancer
Related terms Colonic Neoplasms
Enrollment 11 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov